TSFM
Basic information
Region (hg38): 12:57782761-57808071
Links
Phenotypes
GenCC
Source:
- fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 (Supportive), mode of inheritance: AR
- Leigh syndrome (Moderate), mode of inheritance: AR
- fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Combined oxidative phosphorylation deficiency 3 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Cardiovascular; Gastrointestinal; Musculoskeletal; Neurologic | 17033963; 21119709; 22499341 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (22 variants)
- Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 (2 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TSFM gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 152 | 157 | ||||
missense | 119 | 129 | ||||
nonsense | 13 | 21 | ||||
start loss | 5 | |||||
frameshift | 15 | 17 | 33 | |||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 9 | |||||
splice region | 3 | 36 | 39 | |||
non coding | 30 | 65 | 13 | 108 | ||
Total | 23 | 41 | 160 | 220 | 19 |
Highest pathogenic variant AF is 0.0000329
Variants in TSFM
This is a list of pathogenic ClinVar variants found in the TSFM region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-57782794-C-A | not specified | Likely benign (Dec 03, 2015) | ||
12-57782802-A-G | Conflicting classifications of pathogenicity (Mar 06, 2024) | |||
12-57782802-A-T | Uncertain significance (Jul 06, 2022) | |||
12-57782803-T-C | Uncertain significance (May 23, 2023) | |||
12-57782803-T-G | Skeletal myopathy | Uncertain significance (Oct 12, 2015) | ||
12-57782804-G-A | Uncertain significance (May 29, 2021) | |||
12-57782803-T-TGTCGCTGCTGCG | Uncertain significance (Jun 22, 2022) | |||
12-57782806-C-A | Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 | Pathogenic/Likely pathogenic (Jul 29, 2023) | ||
12-57782806-C-T | Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 | Benign (Jan 30, 2024) | ||
12-57782807-G-C | Likely benign (Dec 09, 2023) | |||
12-57782808-C-T | Likely benign (Nov 03, 2023) | |||
12-57782810-G-A | Likely benign (Mar 09, 2022) | |||
12-57782810-G-T | Likely benign (Jul 10, 2023) | |||
12-57782811-C-T | Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 | Likely benign (Jan 05, 2024) | ||
12-57782812-T-C | Uncertain significance (Jan 07, 2022) | |||
12-57782813-G-A | Likely benign (Dec 01, 2023) | |||
12-57782813-G-T | Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 | Likely benign (Jan 22, 2024) | ||
12-57782814-C-A | Likely benign (Oct 22, 2023) | |||
12-57782818-C-A | Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 | Pathogenic/Likely pathogenic (Feb 19, 2024) | ||
12-57782818-C-G | Uncertain significance (Jun 07, 2022) | |||
12-57782818-C-T | Inborn genetic diseases | Uncertain significance (Jan 23, 2024) | ||
12-57782820-C-T | Likely benign (Sep 29, 2021) | |||
12-57782822-G-T | Likely benign (Nov 12, 2023) | |||
12-57782823-C-T | Inborn genetic diseases | Uncertain significance (Oct 17, 2022) | ||
12-57782824-G-C | Uncertain significance (Jun 07, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TSFM | protein_coding | protein_coding | ENST00000323833 | 7 | 25483 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.92e-9 | 0.132 | 125214 | 0 | 394 | 125608 | 0.00157 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.217 | 177 | 169 | 1.05 | 0.00000829 | 2167 |
Missense in Polyphen | 59 | 63.488 | 0.92931 | 787 | ||
Synonymous | -0.518 | 77 | 71.4 | 1.08 | 0.00000368 | 712 |
Loss of Function | 0.247 | 14 | 15.0 | 0.931 | 7.26e-7 | 198 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000643 | 0.000639 |
Ashkenazi Jewish | 0.000200 | 0.000199 |
East Asian | 0.000164 | 0.000163 |
Finnish | 0.0145 | 0.0138 |
European (Non-Finnish) | 0.000643 | 0.000599 |
Middle Eastern | 0.000164 | 0.000163 |
South Asian | 0.00 | 0.00 |
Other | 0.00124 | 0.00114 |
dbNSFP
Source:
- Function
- FUNCTION: Associates with the EF-Tu.GDP complex and induces the exchange of GDP to GTP. It remains bound to the aminoacyl-tRNA.EF- Tu.GTP complex up to the GTP hydrolysis stage on the ribosome. {ECO:0000255|HAMAP-Rule:MF_03135, ECO:0000269|PubMed:27677415}.;
- Pathway
- Translation;Metabolism of proteins;Mitochondrial translation elongation;Mitochondrial translation
(Consensus)
Recessive Scores
- pRec
- 0.199
Intolerance Scores
- loftool
- 0.376
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 51.92
Haploinsufficiency Scores
- pHI
- 0.175
- hipred
- N
- hipred_score
- 0.394
- ghis
- 0.533
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.513
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tsfm
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); pigmentation phenotype; vision/eye phenotype;
Gene ontology
- Biological process
- translational elongation;regulation of DNA-templated transcription, elongation;mitochondrial translational elongation;regulation of mitochondrial translation
- Cellular component
- nucleus;mitochondrion;mitochondrial matrix
- Molecular function
- RNA binding;translation elongation factor activity;protein binding